Literature DB >> 21234781

A study of six point mutation analysis of LRRK2 gene in Chinese mainland patients with Parkinson's disease.

Z X Hu, D T Peng, M Cai, J L Pu, X G Lei, X Z Yin, Z Y Ou-Yang, W Luo, B R Zhang.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21234781     DOI： 10.1007/s10072-010-0453-8

Source DB:  PubMed          Journal:  Neurol Sci        ISSN： 1590-1874            Impact factor:   3.307


× No keyword cloud information.
  5 in total

1.  G2019S LRRK2 mutation in French and North African families with Parkinson's disease.

Authors:  Suzanne Lesage; Pablo Ibanez; Ebba Lohmann; Pierre Pollak; François Tison; Myriem Tazir; Anne-Louise Leutenegger; Joao Guimaraes; Anne-Marie Bonnet; Yves Agid; Alexandra Dürr; Alexis Brice
Journal:  Ann Neurol       Date:  2005-11       Impact factor: 10.422

2.  The LRRK2 I2012T, G2019S, and I2020T mutations are rare in Taiwanese patients with sporadic Parkinson's disease.

Authors:  Chin-Song Lu; Erik J Simons; Yah-Huei Wu-Chou; Alessio Di Fonzo; Hsiu-Chen Chang; Rou-Shayn Chen; Yi-Hsin Weng; Christan F Rohé; Guido J Breedveld; Nobutaka Hattori; Thomas Gasser; Ben A Oostra; Vincenzo Bonifati
Journal:  Parkinsonism Relat Disord       Date:  2005-10-26       Impact factor: 4.891

Review 3.  Molecular pathogenesis of Parkinson disease: insights from genetic studies.

Authors:  Thomas Gasser
Journal:  Expert Rev Mol Med       Date:  2009-07-27       Impact factor: 5.600

4.  Screening for LRRK2 mutations in patients with Parkinson's disease in Russia: identification of a novel LRRK2 variant.

Authors:  S N Pchelina; A F Yakimovskii; A K Emelyanov; O N Ivanova; A L Schwarzman; A B Singleton
Journal:  Eur J Neurol       Date:  2008-04-24       Impact factor: 6.089

5.  Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease.

Authors:  Wataru Satake; Yuko Nakabayashi; Ikuko Mizuta; Yushi Hirota; Chiyomi Ito; Michiaki Kubo; Takahisa Kawaguchi; Tatsuhiko Tsunoda; Masahiko Watanabe; Atsushi Takeda; Hiroyuki Tomiyama; Kenji Nakashima; Kazuko Hasegawa; Fumiya Obata; Takeo Yoshikawa; Hideshi Kawakami; Saburo Sakoda; Mitsutoshi Yamamoto; Nobutaka Hattori; Miho Murata; Yusuke Nakamura; Tatsushi Toda
Journal:  Nat Genet       Date:  2009-11-15       Impact factor: 38.330
  5 in total
  3 in total

1.  Association between G2385R and R1628P polymorphism of LRRK2 gene and sporadic Parkinson's disease in a Han-Chinese population in south-eastern China.

Authors:  Jiangping Cai; Yi Lin; Wanjin Chen; Qifang Lin; Bin Cai; Ning Wang; Weihong Zheng
Journal:  Neurol Sci       Date:  2013-04-30       Impact factor: 3.307

Review 2.  Review of the epidemiology and variability of LRRK2 non-p.Gly2019Ser pathogenic mutations in Parkinson's disease.

Authors:  Paweł Turski; Iwona Chaberska; Piotr Szukało; Paulina Pyska; Łukasz Milanowski; Stanisław Szlufik; Monika Figura; Dorota Hoffman-Zacharska; Joanna Siuda; Dariusz Koziorowski
Journal:  Front Neurosci       Date:  2022-09-20       Impact factor: 5.152

Review 3.  The Role of LRRK2 in Neurodegeneration of Parkinson Disease.

Authors:  Qin Rui; Haibo Ni; Di Li; Rong Gao; Gang Chen
Journal:  Curr Neuropharmacol       Date:  2018       Impact factor: 7.363
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.